Conventions

EAA conventions are scheduled biannually

The EAA is planning to hold conventions with invited participants from all stakeholder groups to discuss key challenges within the European access environment.


The agenda will include both, a ‘top-down’ health policy perspective by covering key market access strategy trends as well as a ‘bottom-up’ granular HTA perspective by identifying  and discussing  the most heterogeneous and controversial HTA procedures across Europe.


Where feasible, conventions or individual sessions will be made accessible to a wider audience via online-streaming. Further, the proceedings of the EAA conventions will be published.


Current / Upcoming Convention

Save the Date:


EAA Spring Convention 2025


April 3rd, 2025


in Berlin, Germany



Recent Conventions

Video-recordings of the EAA Fall Convention, October 2024,

EU HTA: Transitioning from Preparation to Implementation - Approaching the Pain Points

Mehr lesen

Welcome by Fabrizio Gianfrate (University of Ferrara)  and Jörg Ruof (EAA Secretariat)

Dirk Van den Steen

(Deputy Head of Unit at DG Santé, European Commission)

Marco Marchetti

(Co-Chair at HTA Coordination Group)

Robert Giovanni Nisticò (President at AIFA)





Elias Pèan

(Head of Oncology and Radiopharmaceuticals, EMA)

Robin Doeswijk

(Head of European Affairs, EHA)

François Houÿez

(Director of Treatment Information and Access, EURORDIS)

Bernhard Wörmann

(Medical Superintendent at DGHO & Charité University Medicine)





Nathalie Largeron

(Global Head of HTA Strategy, Sanofi)

Panel Discussion

(E. Pèan, R. Doeswijk, F. Houÿez, B. Wörmann, N. Largeron, Video: M. Marchetti)




Video-recordings of the EAA Spring Convention, April 2024,

EU HTA - Finding the Right Balance

Mehr lesen

Maureen Rutten-van Mölken

(Head of HTA Department at ESHPM, Erasmus University)

Maya Matthews

(Head of Unit at DG Santé, European Commission)

Bernhard Wörmann

(Medical Superintendant at DGHO & Charité University Medicine)

Antonella Cardone

(CEO at Cancer Patients Europe)





Maiwenn Al

(HTA Department at ESHPM, Erasmus University)

Stefan Lange

(former Deputy Head at IQWiG)

Francesco Pignatti

(Scientific Advisor for Oncology at EMA)

Elisabeth de Vries

(Cancer Medicines Committee & MCBS Working Group at ESMO)





Laetitia Mariani

(HTA Collaborations Lead at Abbvie)

Panel Discussion

(B. Wörmann, A. Cardone, M. Al, S. Lange, F. Pignatti, E. de Vries, L. Mariani)

Carin Uyl-de Groot

(HTA Department at ESHPM, Erasmus University)

Michael Ermisch

(Head of Department AMNOG G-BA at GKV-SV






Video-recordings of the EAA Fall Convention, October 2023,

Haemato- / Oncology - A Pace Maker for EU HTA:

Mehr lesen

Caroline Pothet

(Head of Advanced Therapies and Haematological Diseases at EMA)

Roisin Adams

(Chair of the HTA Coordination Group)

Elisabeth de Vries

(Cancer Medicines Committee & MCBS Working Group at ESMO)

César Hernández García

(Director General of Common NHS Portfolio and Pharmacy, Ministry of Health Spain)





Martin Kaiser

(European Hematology Association)

Bernhard Wörmann

(Medical Superintendant at German Society for Hematology and Oncology

 (DGHO))

Brian Cuffel

(VP & Head of Market Access Oncology at Bayer Pharmaceuticals)

Panel Discussion:

(C. Pothet, R. Adams, E. de Vries, M. Kaiser, B. Wörmann, B. Cuffel; O. Solà-Morales, J. Ruof)


Video-recordings of the EAA Spring Convention, April 2023,

Midterms & Status of the Preparation Phase of the EU HTA Regulation:

Mehr lesen

Maya Matthews

(Head of Unit at DG Santé, European Commission)

Michael Berntgen

(Head of Scientific Evidence Generation Department, EMA)

Valentina Strammiello

(Director of Programmes, European Patients’ Forum)

Renato Bernardini

(Professor of Pharmacology, University of Catania School of Medicine & Deputy President, AIFA)





Michal Ermisch

(Division of Pharmaceuticals, National Association of Statutory Health Insurance Funds, Germany)

Ansgar Hebborn

(Head, European Access Policy Affairs, Roche & Chair of the HTA Working Group, EFPIA)

Andrew Wilson

(Chair, Pharmaceutical Benefits Advisory Committee, Australian Department of Health and Aged Care &  Co-Director, Menzies Centre for Health Policy and Economics, University of Sydney)

Panel Discussion:

(M. Matthews, M. Berntgen, V. Strammiello, R. Bernardini, M. Ermisch, A. Hebborn, A. Wilson)

Click here for the complete proceedings of past EAA Conventions.

Share by: